Fuso Pharmaceutical Industries,Ltd. (JP:4538)
:4538
Want to see JP:4538 full AI Analyst Report?
Total Valuation
Fuso Pharmaceutical Industries,Ltd. has a market cap or net worth of ¥17.88B. The enterprise value is ¥41.01B.
Market Cap¥17.88B
Enterprise Value¥41.01B
Share Statistics
Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,451,169
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fuso Pharmaceutical Industries,Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.34%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)3.34%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee45.48M
Profits Per Employee1.47M
Employee Count1,370
Asset Turnover0.69
Inventory Turnover2.95
Valuation Ratios
The current PE Ratio of Fuso Pharmaceutical Industries,Ltd. is 8.5. Fuso Pharmaceutical Industries,Ltd.’s PEG ratio is -0.06.
PE Ratio8.5
PS Ratio0.32
PB Ratio0.58
Price to Fair Value0.58
Price to FCF-2.69
Price to Operating Cash Flow0.00
PEG Ratio-0.06
Income Statement
In the last 12 months, Fuso Pharmaceutical Industries,Ltd. had revenue of 62.31B and earned 2.01B in profits. Earnings per share was 235.52.
Revenue62.31B
Gross Profit15.99B
Operating Income2.64B
Pretax Income2.44B
Net Income2.01B
EBITDA5.26B
Earnings Per Share (EPS)235.52
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Fuso Pharmaceutical Industries,Ltd. pays an annual dividend of ¥45, resulting in a dividend yield of 3.71%
Dividend Per Share¥45
Dividend Yield3.71%
Payout Ratio35.79%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change-1.83%
50-Day Moving Average2.23K
200-Day Moving Average2.21K
Relative Strength Index (RSI)28.46
Average Volume (3m)17.49K
Important Dates
Fuso Pharmaceutical Industries,Ltd. upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 12, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Fuso Pharmaceutical Industries,Ltd. as a current ratio of 1.11, with Debt / Equity ratio of 81.19%
Current Ratio1.11
Quick Ratio0.81
Debt to Market Cap1.41
Net Debt to EBITDA4.49
Interest Coverage Ratio8.05
Taxes
In the past 12 months, Fuso Pharmaceutical Industries,Ltd. has paid 426.00M in taxes.
Income Tax426.00M
Effective Tax Rate0.17
Enterprise Valuation
Fuso Pharmaceutical Industries,Ltd. EV to EBITDA ratio is 8.33, with an EV/FCF ratio of -5.85.
EV to Sales0.70
EV to EBITDA8.33
EV to Free Cash Flow-5.85
EV to Operating Cash Flow-7.04
Balance Sheet
Fuso Pharmaceutical Industries,Ltd. has ¥3.16B in cash and marketable securities with ¥28.23B in debt, giving a net cash position of -¥25.07B billion.
Cash & Marketable Securities¥3.16B
Total Debt¥28.23B
Net Cash-¥25.07B
Net Cash Per Share-¥2.65K
Tangible Book Value Per Share¥4.11K
Margins
Gross margin is 25.67%, with operating margin of 4.24%, and net profit margin of 3.23%.
Gross Margin25.67%
Operating Margin4.24%
Pretax Margin3.91%
Net Profit Margin3.23%
EBITDA Margin8.44%
EBIT Margin4.24%
Analyst Forecast
The average price target for Fuso Pharmaceutical Industries,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.88%
EPS Growth Forecast―